Abstract
Introduction
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders of haematopoietic stem cells, characterised by ineffective haematopoiesis leading to peripheral cytopenias and hypercellular bone marrow, with increased propensity to progression to acute myeloid leukaemia. Anaemia is the most common symptom: it may precipitate symptoms in patients with cardiac disorders, thus affecting the patients' outcome. [...]
Downloads
- Abstract viewed - 239 times
- PDF downloaded - 34 times